The Use of Rocuronium and Sugammadex on a Patient with Multiple Sclerosis

Abstract

ultiple sclerosis (MS) is a chronic inflammatory, demyelinizing autoimmune illness which affects the central nervous system. The illness emerges with sudden symptoms related to vision and other senses, or, partial or complete paralysis. Perioperative stress, emotional instability, anesthesia and increased body temperature may aggravate MS attacks. 1,2 One of the challenges in practice of anesthesia seen in MS patients is the neuromuscular block and the inability to completely reverse this effect. The lack of full recovery of muscular strength may cause a big problem in these patients. 3 Hence, the anesthesiologist must choose the most suitable and the most secure method for the patient. Sugammadex, with a gammacyclodextrin structure, is a selective agent which encapsulates relaxant mus-Turkiye Klinikleri J Anest Reanim 2018;16(2):63-6 63 Gamze TALİH, a